Imperva (IMPV) Tops Q2 EPS by 13c, Q3 & FY Guidance Beats
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Imperva's (IMPV) Price Target Raised to $80 at Pacific Crest on Solid Q2 Results
August 7, 2015 10:22 AM EDTPacific Crest maintained an Overweight rating on Imperva (NYSE: IMPV) and raised its price target to $80.00 (from $67.00). The change follows strong Q2 results and guidance.
Analyst Rob Owens said, "We are increasing our target and remain buyers of IMPV. Improving execution and a... More
Imperva (IMPV) PT Raised to $88 at Needham & Company Amid Strong June Quarter
August 7, 2015 7:47 AM EDTNeedham & Company analyst Scott Zeller reiterated a Buy rating and boosted his price target on Imperva (NYSE: IMPV) to $88.00 (from $67.00) after a strong June quarter.
Zeller commented, "The IMPV JuneQ results were very strong, and license accelerated (a bit)... More
Oppenheimer Raises Price Target on Imperva (IMPV) to $80 Following 2Q15 Results
August 7, 2015 7:03 AM EDTOppenheimer reiterated an Outperform rating on Imperva (NYSE: IMPV), and raises the price target to $80.00 (from $75.00), following 2Q15 results. Revenue of $53.5M (up 39% YoY) bested consensus $48.7M estimate. Loss per share of $0.08 came in better than our and Street's estimate of $0.21. For... More
